Softwr

Research · head to head

Genedata vs Labguru

Genedata logo

Genedata

Research

Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher

From
On request
Rated
-
Labguru logo

Labguru

Research

Electronic lab notebook, LIMS and inventory in one system, now sold under the Cenevo group

From
On request
Rated
-

The short version

  • Each has a real cost: Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.; Labguru ownership changed twice in short order, to Battery Ventures in 2024 and then into the Cenevo brand with Titian Software in 2025, so the medium-term roadmap is a group strategy decision rather than a product one and buyers should ask directly what happens to the notebook.
  • They diverge on capability: Genedata covers Screener, Labguru covers Combined ELN and LIMS.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which Genedata and Labguru actually diverge.

Attributes where Genedata and Labguru differ
AttributeGenedataLabguru
PlatformsWeb, On-premise, Private cloudWeb, iOS, Android, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Genedata

  • Screener
  • Biologics
  • Bioprocess
  • Expressionist
  • Selector
  • Profiler
  • Instrument integration
  • GxP-capable deployments

Only in Labguru

  • Combined ELN and LIMS
  • Validated cloud hosting
  • Inventory and stock
  • Chemistry module
  • Equipment management
  • Electronic batch records
  • Label Wizard
  • API and developer tools

What people use each for

The jobs each tool is most often brought in to do.

Genedata

  • A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot Labguru
  • A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot Labguru
  • A process development group standardising bioprocess run data across sites for modelling and scale-upnot Labguru
  • A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot Labguru

Labguru

  • A biotech that wants experiment records and sample inventory in one system instead of paying for an ELN and a LIMS separatelynot Genedata
  • A chemistry group needing structure registration attached to the experiment rather than in a standalone databasenot Genedata
  • A contract research organisation that must show sample traceability from receipt to reported result during a client auditnot Genedata
  • An academic institute standardising dozens of small labs off shared spreadsheets and paper notebooks onto one searchable recordnot Genedata

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Genedata

  • There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
  • Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
  • Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
  • Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
  • Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.

Labguru

  • Ownership changed twice in short order, to Battery Ventures in 2024 and then into the Cenevo brand with Titian Software in 2025, so the medium-term roadmap is a group strategy decision rather than a product one and buyers should ask directly what happens to the notebook.
  • The validated GxP hosting option is a separate commercial line, not a configuration setting, so a lab that discovers mid-project that it needs a validated instance faces a new contract and a new price rather than an upgrade.
  • Being both an ELN and a LIMS means it is shallower than dedicated tools in each role; high-throughput sample management and deep bioinformatics workflows both hit limits that a specialist would not.
  • No pricing is published at all, and modules such as chemistry, batch records and equipment are quoted on top, so the real annual figure only appears after a sales process.
  • Validation, SOPs and periodic revalidation after vendor releases are the customer obligation on a regulated instance, and cloud release cadence means that revalidation is a recurring internal cost that never appears on the vendor quote.

Pricing, plan by plan

Genedata

On request
  • Genedata platform licence$undefined/year
    • Each platform, such as Screener or Biologics, licensed separately
    • Annual enterprise subscription scoped on users, sites and data volume
    • Implementation and scientific configuration services quoted as a separate programme

Labguru

On request
  • Labguru$undefined/year
    • Priced per user per year on quotation with volume tiers
    • ELN, LIMS and inventory in the base platform
    • Chemistry, batch records and equipment modules quoted separately

Which should you pick?

Choose Genedata if

  • You need screener.
  • You work on Web, On-premise, Private cloud.
  • You also want biologics.

Choose Labguru if

  • You need combined eln and lims.
  • You work on Web, iOS, Android, On-premise.
  • You also want validated cloud hosting.

Questions people ask

Is Genedata or Labguru better?
Neither clearly leads. Genedata starts at On request and Labguru at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Genedata or Labguru?
Genedata starts at On request and Labguru at On request.
Does Genedata or Labguru run on more platforms?
Genedata runs on Web, On-premise, Private cloud. Labguru runs on Web, iOS, Android, On-premise.
What is Genedata best used for?
Genedata is most often used for a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale, a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets, a process development group standardising bioprocess run data across sites for modelling and scale-up, a cro delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelines. Of those, a pharmaceutical screening group processing thousands of plates a week where manual qc and curve fitting no longer scale and a biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheets are not what Labguru is typically brought in for.
What can Genedata do that Labguru cannot?
Genedata covers Screener, Biologics, Bioprocess, Expressionist. Labguru covers Combined ELN and LIMS, Validated cloud hosting, Inventory and stock, Chemistry module.

Answered from the vendors’ own pages

Genedata: Who owns Genedata?

Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.

Labguru: Who owns Labguru now?

Battery Ventures acquired it in April 2024. Since July 2025 it operates under the Cenevo brand following a merger with Titian Software.

Genedata: Is there a small-team or starter option?

No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.

Labguru: Is it an ELN or a LIMS?

Both, in one product. That is the main reason labs choose it, and also why it is shallower than a specialist in each role.

Genedata: Do I buy one product or the whole suite?

Each platform is licensed separately. Most customers license two or three and integrate between them.

Labguru: Does it support GxP work?

Yes, through a separately contracted validated cloud instance. Validation for your intended use remains your responsibility.

Genedata: Can it be used in a GxP environment?

Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.

Labguru: Is pricing published?

No. It is quoted per user per year, with modules and validated hosting priced on top.

Share

Related pages

Other head to heads